An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
Clinical trial NCT03243331 · COMPLETED
Trial details
- NCT number
- NCT03243331
- Sponsor
- Kathy Miller
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-19
- Primary completion
- 2020-05-27
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.